
Nicky Mehtani
Internal Medicine · City and County of San Francisco
Credentials: · · ·
History
Research
COVID-19: A catalyst for change in telehealth service delivery for opioid use disorder management
Substance Abuse · 2021 · First of 7 authors · 35 citations
Journal of acquired immune deficiency syndromes · 2024 · First of 7 authors · 26 citations
Continued Importance of Sexually Transmitted Disease Clinics in the Era of the Affordable Care Act
American Journal of Preventive Medicine · 2016 · First of 8 authors · Corresponding · 15 citations

7 papers

4 papers

4 papers

3 papers · 3 as a fellow

3 papers
- BZ
2 papers
- CC
2 papers
- CS
2 papers
Grants
- 2026–2030
Psilocybin Therapy for Methamphetamine Use Disorder and HIV
National Institute on Drug Abuse · DP2
Contact PI · $2.5M · University of California, San Francisco
Clinical trials
- 2026–2029
Psilocybin Therapy for Methamphetamine Use Disorder and HIV
Principal investigator · Not yet recruiting · Phase 2
Nicky Mehtani, MD, MPH
- 2025–2026
Ketamine-Assisted Recovery for Methamphetamine Use Disorder & HIV
Principal investigator · Completed · Phase 2
Nicky Mehtani, MD, MPH

